-
EP3356542
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3356542
| EP3356542 - MODIFIED LYSOSOMAL PROTEIN AND PRODUCTION THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.07.2020 Database last updated on 19.10.2024 | |
| Former | Examination is in progress Status updated on 28.03.2019 | ||
| Former | Request for examination was made Status updated on 06.07.2018 | ||
| Former | The international publication has been made Status updated on 08.04.2017 | ||
| Former | unknown Status updated on 21.12.2016 | Most recent event Tooltip | 03.07.2020 | Application deemed to be withdrawn | published on 05.08.2020 [2020/32] | Applicant(s) | For all designated states Swedish Orphan Biovitrum AB 112 76 Stockholm / SE | [N/P] |
| Former [2018/32] | For all designated states Swedish Orphan Biovitrum AB (Publ) 112 76 Stockholm / SE | Inventor(s) | 01 /
NORDLING, Erik Sportstugevägen 14A 182 35 Danderyd / SE | 02 /
STRÖMBERG, Patrik Kamomillvägen 6 191 64 Sollentuna / SE | 03 /
SVENSSON GELIUS, Stefan Segeltorpsvägen 48 125 53 Älvsjö / SE | [2018/32] | Representative(s) | AWA Sweden AB Box 45086 104 30 Stockholm / SE | [N/P] |
| Former [2018/32] | AWA Sweden AB P.O. Box 45086 104 30 Stockholm / SE | Application number, filing date | 16775701.2 | 30.09.2016 | [2018/32] | WO2016EP73452 | Priority number, date | EP20150187877 | 01.10.2015 Original published format: EP 15187877 | [2018/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017055570 | Date: | 06.04.2017 | Language: | EN | [2017/14] | Type: | A1 Application with search report | No.: | EP3356542 | Date: | 08.08.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.04.2017 takes the place of the publication of the European patent application. | [2018/32] | Search report(s) | International search report - published on: | EP | 06.04.2017 | Classification | IPC: | C12P21/02, A61K38/43, C12P21/00, A61K38/47 | [2018/32] | CPC: |
C12N9/14 (EP,KR,US);
A61P11/00 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
C12N9/16 (EP,US);
C12N9/2402 (EP,US);
C12Y301/06013 (EP,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/32] | Extension states | BA | 27.04.2018 | ME | 27.04.2018 | Title | German: | MODIFIZIERTES LYSOSOMALES PROTEIN UND HERSTELLUNG DAVON | [2018/32] | English: | MODIFIED LYSOSOMAL PROTEIN AND PRODUCTION THEREOF | [2018/32] | French: | PROTÉINE LYSOSOMALE MODIFIÉE ET SA PRODUCTION | [2018/32] | Entry into regional phase | 27.04.2018 | National basic fee paid | 27.04.2018 | Designation fee(s) paid | 27.04.2018 | Examination fee paid | Examination procedure | 27.04.2018 | Amendment by applicant (claims and/or description) | 27.04.2018 | Examination requested [2018/32] | 27.04.2018 | Date on which the examining division has become responsible | 01.04.2019 | Despatch of a communication from the examining division (Time limit: M06) | 01.10.2019 | Reply to a communication from the examining division | 24.10.2019 | Despatch of a communication from the examining division (Time limit: M04) | 04.03.2020 | Application deemed to be withdrawn, date of legal effect [2020/32] | 31.03.2020 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/32] | Fees paid | Renewal fee | 20.08.2018 | Renewal fee patent year 03 | 15.08.2019 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XAYI]WO2008109677 (UNIV SAINT LOUIS [US], et al) [X] 21-24 * p.1 l.10-14,p.2 l.8-12,p.3 l.5-19,p.8 l.5-20,p.3 l.20-30, p.4 l.25- p.5 l.10,p.4 l.2-5, l.11-12 * [A] 1-5 [Y] 6-14 [I] 15-20; | [Y]US2010015684 (DEFREES SHAWN [US], et al) [Y] 6-14 * Par.387 - 389 *; | [XAY] - YU MENG ET AL, "Systemic Administration of Tripeptidyl Peptidase I in a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis: Effect of Glycan Modification", PLOS ONE, (20120706), vol. 7, no. 7, doi:10.1371/journal.pone.0040509, page e40509, XP055278528 [X] 21-24 * p.5 col.1 par.4, p.6 col.2 par.1, p.2 col.1 par.1, p.5 col.1 par.4, p.5 col.2 par.1, 2 * [A] 1-5 [Y] 6-14 DOI: http://dx.doi.org/10.1371/journal.pone.0040509 | [A] - TINA ROZAKLIS ET AL, "Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA", EXPERIMENTAL NEUROLOGY, (20110701), vol. 230, no. 1, doi:10.1016/j.expneurol.2011.04.004, ISSN 0014-4886, pages 123 - 130, XP055063151 [A] 15 * p.123 col.1 par.1, p.124 col.1 par.3, p.129 col.1 par.5 * DOI: http://dx.doi.org/10.1016/j.expneurol.2011.04.004 | [A] - AKIHIKO URAYAMA, "Toward the successful delivery of lysosomal enzymes across the blood-brain barrier", CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, (20130801), vol. 4, no. 2, doi:10.1111/cen3.12037, ISSN 1759-1961, pages 228 - 238, XP055287085 [A] 22-24 * p.230 col.2 par.2, 3; p.234 col.2 par.2, p.235 col.1,2; p.236 col.1 par.2 * DOI: http://dx.doi.org/10.1111/cen3.12037 |